Consumer demands lead commercial performance and a brand that doesn’t satisfy ethical needs can be a real roadblock to success in the health and nutrition sector, he says.
The business has seen a significant shift in market priorities from the point of view of both customers and consumers, he explains, which will see pharmaceuticals, commercial health and wellbeing, functional ingredients and biomedical technology companies leverage sustainability as a competitive edge.
As such, the company is reviewing its entire supply chain from sourcing and manufacturing to logistics, resulting to “progressive changes” to align with market expectations and achieve its five-year sustainable target.
Rehné comments: “Our team is currently in the phase of roadmapping how we will achieve this, but what remains key is that we do this in a data-led way, making every single element more measurable.”
Evolution, not revolution
Clasado will take an analytical approach to the business review “to understand where our operations currently sit” and identify areas where it can make “operations ‘greener’ – in a meaningful way”.
“When it comes to building a more sustainable business, it’s definitely a case of evolution, not revolution. Through the full length of our supply chain, we aim to make smaller, more numerous improvements rather than sweeping changes,” Rehné explains.
“This approach means we can measure and monitor our performance and improve our environmental performance gradually and organically.”